IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4265 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (591 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
    Study Subjects
Sample Size Calc...
    Randomization
    Blinding
Statistical Meth...
    Ethical Issues
   References

 Article Access Statistics
    Viewed1471    
    Printed12    
    Emailed0    
    PDF Downloaded48    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTERS TO THE EDITOR - LETTER IN RESPONSE TO PREVIOUSLY PUBLISHED ARTICLES
Year : 2018  |  Volume : 84  |  Issue : 3  |  Page : 309-310

In response to “Effectiveness of topical green tea against multidrug-resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial”


Department of Dermatology, Venereology and Leprosy, Medical College and Hospitals, Kolkata, West Bengal, India

Date of Web Publication04-Apr-2018

Correspondence Address:
Prof. Debabrata Bandyopadhyay
Department of Dermatology, Venereology and Leprosy, Medical College and Hospitals, Kolkata, 88, College Street, Kolkata - 700 073, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijdvl.IJDVL_158_18

Rights and Permissions



How to cite this article:
Bandyopadhyay D. In response to “Effectiveness of topical green tea against multidrug-resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial”. Indian J Dermatol Venereol Leprol 2018;84:309-10

How to cite this URL:
Bandyopadhyay D. In response to “Effectiveness of topical green tea against multidrug-resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial”. Indian J Dermatol Venereol Leprol [serial online] 2018 [cited 2020 Jun 6];84:309-10. Available from: http://www.ijdvl.com/text.asp?2018/84/3/309/229317


Sir,

I read with interest the article “Effectiveness of topical green tea against multidrug-resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial” published in the March–April (2018) issue of the journal.[1] The article raises more questions in the mind of the reader than it seeks to answer. I would like the authors to clarify the following issues.


  Study Subjects Top


As the title suggested, the authors have compared the effectiveness of two treatment regimens against multidrug-resistant S. aureus, but not all study participants had multidrug-resistant S. aureus infection. According to the authors, 89.1% in the green tea group and 81.1% in the placebo group had multidrug-resistant S. aureus.


  Sample Size Calculation Top


The importance of sample size calculation for determining the requisite number of participants in clinical trials cannot be overemphasized. A valid conclusion about the difference between the efficacy of two (or more) treatment regimens can only be drawn if an adequate sample size is planned in advance using appropriate statistical methods. Sample size calculation for clinical trials requires consideration of predefined effect size, statistical power and the level of significance. The authors have erroneously used a formula for calculating sample size for prevalence studies rendering the whole exercise futile.


  Randomization Top


Randomization is an essential prerequisite of any good quality clinical trial. It ensures that the treatment groups are comparable and eliminates the source of bias in assigning trial participants to different treatment regimens. Nonrandom or pseudorandom allocation of participants to treatment groups cannot have the desirable properties of a truly randomized procedure. A computer-generated randomization schedule is currently the standard method of randomization. The authors have stated that true randomization was not done without mentioning any reason. The authors could have easily followed a randomization schedule for the participants with a 1:2 allocation ratio using a statistical software package or easily available, free online resources.


  Blinding Top


Blinding is another important strategy to eliminate bias in the treatment or assessment of the outcome of a controlled trial. The authors have not assigned any reason for not following at least an assessor-blinded procedure.


  Statistical Methods Used Top


According to the authors, their “data were analyzed by mean, standard deviation and Chi-square tests.” In Table 1, figures for three variables (age, duration and sex) were tabulated, but a single P value is mentioned. How did the authors calculate a composite P value for these disparate variables?How were the means of continuous variables such as age and duration of lesions compared by Chi-square test?


  Ethical Issues Top


The authors studied participants belonging to the age group of 8–16 years “as the school authorities did not permit for younger children to be included in the study.” The authors have also mentioned that “written informed consent was obtained before study enrollment.” Who signed the informed consent?Were the school authorities legally authorized to allow the children to participate in an experimental study? In conducting research with minors (e.g. in the age group 7–17), in addition to informed consent from parents/legal guardians, assent must be obtained from the participants. Was this procedure followed by the authors?

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Umashankar N, Pemmanda B, Gopkumar P, Hemalatha AJ, Sundar PK, Prashanth HV, et al. Effectiveness of topical green tea against multidrug-resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial. Indian J Dermatol Venereol Leprol 2018;84:163-8.  Back to cited text no. 1
[PUBMED]  [Full text]  




 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow